Celldex Therapeutics Inc (CLDX)
38.79
-0.30
(-0.77%)
USD |
NASDAQ |
Apr 16, 09:34
Celldex Therapeutics Enterprise Value: 1.762B for April 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 1.762B |
| April 12, 2024 | 1.771B |
| April 11, 2024 | 1.861B |
| April 10, 2024 | 1.767B |
| April 09, 2024 | 1.847B |
| April 08, 2024 | 1.798B |
| April 05, 2024 | 1.789B |
| April 04, 2024 | 1.788B |
| April 03, 2024 | 1.832B |
| April 02, 2024 | 1.877B |
| April 01, 2024 | 1.904B |
| March 28, 2024 | 1.923B |
| March 27, 2024 | 1.912B |
| March 26, 2024 | 1.871B |
| March 25, 2024 | 1.893B |
| March 22, 2024 | 1.924B |
| March 21, 2024 | 1.869B |
| March 20, 2024 | 1.933B |
| March 19, 2024 | 1.840B |
| March 18, 2024 | 1.866B |
| March 15, 2024 | 1.925B |
| March 14, 2024 | 1.953B |
| March 13, 2024 | 2.110B |
| March 12, 2024 | 2.151B |
| March 11, 2024 | 2.178B |
| Date | Value |
|---|---|
| March 08, 2024 | 2.255B |
| March 07, 2024 | 2.201B |
| March 06, 2024 | 2.290B |
| March 05, 2024 | 2.372B |
| March 04, 2024 | 2.411B |
| March 01, 2024 | 2.477B |
| February 29, 2024 | 2.263B |
| February 28, 2024 | 2.448B |
| February 27, 2024 | 2.430B |
| February 26, 2024 | 2.272B |
| February 23, 2024 | 1.687B |
| February 22, 2024 | 1.669B |
| February 21, 2024 | 1.685B |
| February 20, 2024 | 1.729B |
| February 16, 2024 | 1.715B |
| February 15, 2024 | 1.634B |
| February 14, 2024 | 1.603B |
| February 13, 2024 | 1.547B |
| February 12, 2024 | 1.677B |
| February 09, 2024 | 1.702B |
| February 08, 2024 | 1.673B |
| February 07, 2024 | 1.689B |
| February 06, 2024 | 1.655B |
| February 05, 2024 | 1.647B |
| February 02, 2024 | 1.562B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-51.61M
Minimum
Jun 12 2019
2.477B
Maximum
Mar 01 2024
905.75M
Average
998.50M
Median
Enterprise Value Benchmarks
| ThermoGenesis Holdings Inc | 2.566M |
| Perspective Therapeutics Inc | 890.47M |
| Electromed Inc | 115.63M |
| Xtant Medical Holdings Inc | 128.06M |
| Asensus Surgical Inc | 53.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.31M |
| Revenue (Quarterly) | 4.131M |
| Total Expenses (Quarterly) | 39.26M |
| EPS Diluted (Quarterly) | -0.84 |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -7.53% |
| Normalized Earnings Yield | -7.603 |